Summary & Overview
HCPCS A2013: Innovamatrix fs, Biologic Matrix per sq cm
HCPCS Level II code A2013 designates Innovamatrix fs billed per square centimeter as an add-on supply used in wound and tissue repair procedures. As an adjunctive biologic matrix item, it is reported in addition to a primary procedure and is relevant for accurate claim construction, coding compliance, and supply cost tracking across outpatient and ambulatory wound care settings. Nationally, add-on supply codes like A2013 matter because they affect reimbursement for complex wound care, influence cost-sharing calculations, and interact with payer-specific coverage policies for biologic products.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical role of Innovamatrix fs, typical sites of service, and the implications of per-square-centimeter billing. The publication outlines what to expect in payer coverage determinations, documentation needs, and where to look for policy updates. It also presents benchmarks and coding considerations relevant to billing teams and revenue cycle managers, plus guidance on interpreting add-on supply reporting versus bundled supply reporting. Data not available in the input is identified where applicable.
Billing Code Overview
HCPCS Level II code A2013 describes Innovamatrix fs, billed per square centimeter as an add-on supply item that is reported separately in addition to a primary procedure. The service type is a wound care/biologic matrix application used to support tissue repair, billed by surface area. The typical site of service is ambulatory wound care settings, outpatient clinics, and other settings where a primary procedure addressing a wound or tissue defect is performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic or complex wound (e.g., diabetic foot ulcer, venous stasis ulcer, pressure ulcer, or surgical dehiscence) requiring advanced wound bed preparation. The clinician (often a podiatrist, wound care specialist, or plastic surgeon) evaluates the wound in an outpatient wound clinic or inpatient service, documents wound size in square centimeters, determines that placement of Innovamatrix fs (a bioengineered skin substitute or matrix) is appropriate as an add-on to the primary procedure, and orders the material. The procedure often occurs in an ambulatory surgery center, hospital outpatient department, or inpatient operating room depending on wound severity and patient comorbidities. Typical workflow: wound assessment and measurement; debridement or primary procedure (e.g., excision, closure, grafting) coded separately; selection and application of Innovamatrix fs measured and billed per square centimeter with A2013 as an add-on supply; documentation of wound dimensions, indications, informed consent, and the identity and quantity (cm2) of the product applied; and post-procedure wound care instructions and follow-up scheduling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies. |